How I Do It: Temporary RVAD Placed at the Time of Implantation of a HeartMate II LVAD
AbstractLeft ventricular assist devices (LVAD) are increasingly used to support patients as they await heart transplantation and as destination therapy for patients with end-stage cardiac failure. While the methods of LVAD implantation have become fairly standardized, early postoperative management of patients receiving these devices remains challenging. One issue that has plagued surgeons, cardiologists, and intensivists caring for patients after LVAD implantation is right heart dysfunction. While many scoring systems have been developed to try to anticipate RV failure, the accuracy of these predictive tools remains low. We present a novel approach of implantation of a temporary right ventricular assist devices (RVAD) during LVAD implantation with subsequent weaning in the immediate postoperative period, utilizing a strategy that does not require a return to the operating room for removal of the RVAD cannulas.
Buchanan SA, Langenburg SE, Mauney MC, et al. 1994. Ambulatory intra-aortic balloon counterpulsation. Ann Thorac Surg 58:1547-9.
Cowger J, Sundareswaran K, Rogers JG, et al. 2013. Predicting survival in patients receiving continuous flow left ventricular assist devices: the HeartMate II risk score. J Am Coll Cardiol 61:313-21.
De Simone V, Cipriani M, Verde A, et al. 2015. Right ventricular failure after left ventricular assist device implantation: the importance of preoperative hemodynamic profile. J Heart Lung Transplant 34:S198.
Fitzpatrick JR, Fredrick JR, Hsu VM, et al. 2008. Risk score from pre-operative data analysis predicts the need for biventricular mechanical circulatory support. J Heart Lung Transplant 27:1286-92.
Gaffey AC, Alturi P. 2015. Post-left ventricular assist device support right ventricular failure: Can it be predicted preoperatively, and should it be a contraindication to implantation? J Thorac Cardiovasc Surg 150:1659-60.
Haneya A, Phillipp A, Puehler T, et al. 2012. Temporary percutaneous, right ventricular, support using a centrifugal pump in patients with postoperative acute refractory right ventricular failure after left ventricular assist device implantation. Eur J Cardiothorac 41:219-23.
Kang G, Hs R, Banerjee D. 2014. Pulmonary artery pulsatility index predicts right ventricular failure after LVAD implantation. J Heart Lung Transplant 33:S86.
Kormos RL, Teuteberg JJ, Pagani FD, et al. 2010. Right ventricular failure in patients with the HeartMate II continuous flow left ventricular assist device: incidence, risk factors, and effect on outcomes. J Thorac Cardiovasc Surg 139:1316-24.
Lazar JF, Schwartz MF, Schiralli MP, et al. 2013. Survival after left ventricular assist device with and without right ventricular support. Ann Thorac Surg 96:2155-9.
Leitz K, Long JW, Khoury AG, et al. 2007. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection. Circulation 116:497-505.
Lo C, Murphy D, Summerhayes R, et al. 2015. Right ventricular failure after implantation of continuous flow left ventricular assist device: analysis of predictors and outcomes. Clin Transplant 29:763-70.
Matthews JC, Pagani FD, Haft JW, Koelling TM, Naftel DC, Aronson KD. 2010. Model for end-stage liver disease predicts left ventricular assist device transfusion requirements, morbidity, and mortality. Circulation 121:214-20.
Patil NP, Mohite PN, Sabashnikov A, et al. 2015. Preoperative predictors and outcomes of right ventricular assist device implantation after continuous-flow left ventricular assist device implantation. J Thorac Cardiovasc Surg 150:1651-8.
Patlolla B, Beygui R, Haddad F. 2013. Right-ventricular failure following left ventricle assist device implantation. Curr Opin Cardiol 8:223-33.
Takeda K, Naka Y, Yang JA, et al. 2014. Outcome of unplanned right ventricular assist device support for severe right heart failure after implantable left ventricular assist device insertion. J Heart Lung Transplant 33:141-8.
How to Cite
Author Disclosure & Copyright Transfer Agreement
In order to publish the original work of another person(s), The Heart Surgery Forum® must receive an acknowledgment of the Author Agreement and Copyright Transfer Statement transferring to Forum Multimedia Publishing, L.L.C., a subsidiary of Carden Jennings Publishing Co., Ltd. the exclusive rights to print and distribute the author(s) work in all media forms. Failure to check Copyright Transfer agreement box below will delay publication of the manuscript.
A current form follows:
The author(s) hereby transfer(s), assign(s), or otherwise convey(s) all copyright ownership of the manuscript submitted to Forum Multimedia Publishing, LLC (Publisher). The copyright transfer covers the exclusive rights to reproduce and distribute the article and the material contained therein throughout the world in all languages and in all media of expression now known or later developed, including but not limited to reprints, photographic reproduction, microfilm, electronic data processing (including programming, storage, and transmission to other electronic data record(s), or any other reproductions of similar nature), and translations.
However, Publisher grants back to the author(s) the following:
- The right to make and distribute copies of all or part of this work for use of the author(s) in teaching;
- The right to use, after publication in The Heart Surgery Forum, all or part of the material from this work in a book by the author(s), or in a collection of work by the author(s);
- The royalty-free right to make copies of this work for internal distribution within the institution/company that employs the author(s) subject to the provisions below for a work-made-for-hire;
- The right to use figures and tables from this work, and up to 250 words of text, for any purpose;
- The right to make oral presentations of material from this work.
Publisher reserves the right to grant or refuse permission to third parties to republish all or part of the article or translations thereof. To republish, such third parties must obtain written permission from the Publisher. (This is in accordance with the Copyright Statute, United States Code, Title 17. Exception: If all authors were bona fide officers or employees of the U.S. Government at the time the paper was prepared, the work is a “work of the US Government” (prepared by an officer or employee of the US Government as part of official duties), and therefore is not subject to US copyright; such exception should be indicated on signature lines. If this work was prepared under US Government contract or grant, the US Government may reproduce, royalty-free, all or portions of this work and may authorize others to do so, for official US Government purposes only, if the US Government contract or grant so requires.
I have participated in the conception and design of this work and in the writing of the manuscript and take public responsibility for it. Neither this manuscript nor one with substantially similar content under my authorship has been published, has been submitted for publication elsewhere, or will be submitted for publication elsewhere while under consideration by The Heart Surgery Forum, except as described in an attachment. I have reviewed this manuscript (original version) and approve its submission. If I am listed above as corresponding author, I will provide all authors with information regarding this manuscript and will obtain their approval before submitting any revision. I attest to the validity, accuracy, and legitimacy of the content of the manuscript and understand that Publisher assumes no responsibility for the validity, accuracy, and legitimacy of its content. I warrant that this manuscript is original with me and that I have full power to make this Agreement. I warrant that it contains no matter that is libelous or otherwise unlawful or that invades individual privacy or infringes any copyright or other proprietary right. I agree to indemnify and hold Publisher harmless of and from any claim made against Publisher that relates to or arises out of the publication of the manuscript and agree that this indemnification shall include payment of all costs and expenses relating to the defense of any such claim, including all reasonable attorney’s fees.
I warrant that I have no financial interest in the drugs, devices, or procedures described in the manuscript (except as disclosed in the attached statement).
I state that the institutional Human Subjects Committee and/or the Ethics Committee approved the clinical protocol reported in this manuscript for the use of experimental techniques, drugs, or devices in human subjects and appropriate informed consent documents were utilized.
Furthermore, I state that any and all animals used for experimental purposes received humane care in USDA registered facilities in compliance with the “Principles of Laboratory Animal Care” formulated by the National Society for Medical Research and the “Guide for the Care and Use of Laboratory Animals” prepared by the Institute of Laboratory Animal Resources and published by the National Institutes of Health (NIH Publication No. 85-23, revised 1985).